Gene search

Sequence information

Select Gene Cds Cds_length GC_content Pep Pep_length
Pvu2g1011 ATGCTAGATGGGGGTATCAAAAGCAGCACCAGACTTAGACAATCATCATCATGCTCATGTCCACCCAGAATGGTTAAAATTTCACCTGAGCCTTCTTCTTCCTCTTTCTCTTCTACAGCACCTCTTAAAAGACACGATGTTTTCATCAGTTTTAGAGGTGAGGACACGCGCAGCGGCTTCACAAGCCATCTCTATGCAGCCTTTCAGCACAACAAGATCCAAGCCTTCATAGATAACAGGCTTCACAAAGGGGAAGAGATCTCTCCCTCTATTTTTGAAGCCATCAAACACTCCAACCTATCTCTGGTTGTTCTCTCCAAGTACTATGCTTCCTCCACCTGGTGCTTGCGTGAACTTGCCAAAATACTTGAACTCAAGAAACGTGGAGGACACACTGTGATACCTGTTTTCTATAAGATTGATCCTTCCCATGTACGGAAGCAGACTGGAACTTACGGGATGGCGTTTCAAAAATATCAAAGAGATGTTAAACAAAACATGGCCATGTTGCAGAAATGGAAAGCTGCTCTCACTGAAGTGGCCGATATAGTTGGGTGGGAATTAAAGAATTTTAGGACGGAGTATGAACTCATTGGGGAAATTGTCAAAGACGTTATGCAAAAACTAAACCATATGTATCCCACTGAAGTAAAAGAAACACTTGTTGGAATTGATCAAAATCTTGCTCCTATTGAATCTTTATTAAGAATAAGGTCAAAAGAAGTTCGCATAATTGGAATTTGGGGTATGGGTGGATTAGGCAAGACAACCATTGCGGGCGCTTTATTTGCCAAATTATCATCTCAATTTGAAGCTAGTTGCTTCTTGGCAAATGTGAAGGAAGAACATGAAAAGCAAGGACTTGATTATTTACGCAATAAACTTCTTTCTGAGATATTAGAAGATGTGAATCCCCATATAAGCACTTCCAAAGTGAGAACTACGTTTGTTATGAAGAGGCTTAGACAAAAAAAGGTTTTGATAGTGCTTGATGATGTGGACGATCCAAAGAAACTGGAATATCTTGCTGCACAACATGATTGCTTGGGATCTGGTAGTAGAGTCATTGTCACTACAAGAGACAAGCATGTCCTTAGCAGAGGGGTAGATGCAATCTATGAGGTTAAGGGATTGTCCCTTCATCATGCTGTTAGGCTTTTTAGTTTAAATTCCTTCGGCAAAACTTATCCTGAAAGGGGCTTTGAAATGCTATCTAAACAGGCGGTTGATCATGCAAATGGAAATCCACTGGCTTTAAAAGTTTTAGGTTCAGTTCTTCATTCCAGAAATGAGCAGCAATGGGACAATGCTCTGAGAAAATTCAAGAAGGTTCCTAATGCAGAAATTCAGAATGTCTTGAGATGGAGTTATGATAGATTAGATTATGAACAAAAAAACATGTTCCTGGACATTGCATGCTTTTTCCGAGGAGAAAATAAAGAAAATGTTATAAGGCTACTCGATATTTGTGGTTTCTATGCATATATTGGTATAAAAGTGCTTCTAGAAAAAGGTCTTATAACATTTTCTGATGAAGGTAACGTGTGTATGCATGAATTGATACAAGAAATGGGTTGGGAAATTGTTCATCAGGAATCTATCAATGATCCTGGAAGGCGTAGCCGATTGTGGGATCTTAAAGAAGTCTATGATGTATTGAAAAATAACAGGGGAACTGAAGCAGTTGAAGGCATAATCTTAGATGTGTCTCAAGTAAGAGTCCTGCTACTGAACTATGAGACCTTCTCAAGGATGGTGAATATGAGATTTCTCAAATTCTATATGGGGAGGGGTAGGAAATGCAATTTGCACCTTCCTTCAGGTCTCGAATCCTTGCCTAATAAATTAATGTACCTACAATGGGATGGATACCCTTCTAAGTCTCTGCCATCAACTTTTTGTCCTGACAACCTTGTTGTGCTTTCCATGATGGAAAGCCACGTTGAGAAACTTTGGGATGGAATCAAGAGTCTTCCAAGCTTGAAAGAGCTCAACCTCCGTGCCAGCAAAAATTTAACTAAGCTCCCAGATTTATCTCAGGCACCAAATCTTGAAACTATAGATGTTTCCTATTGCACTAGTCTGCTTCATATTCCCTTATCTATCCAACATGTCAAGAGGCTTCTTCTGTTTAACTTGGAATCCTGCAAGAGTCTCAAGAGTCATCCAAGAAACATTCACTTATCTTCTCTTGAAATGTTCATTCTGAGACGCTGTTCTAGTCTTGATGAGTTTCCATTGACTTCAGAGAACATGACACGCCTAGACTTGAGAGAAACAGCAATAGCAGATTTCCCAGAGTCTGTTTGGCAGCATCTGAACAAGCTTGTTTACTTGAATCTGGAATCCTGCAACAAACTCAAGAATCTTACAAGCAAGATTCACTTAAAATCTCTTCAAATTCTCAATATGAGAGATTGTTCAATTCTTGAAGAGTTTTCTGTGACTTCGGAGAACATGGAATACTTGAATTTGAGAGGCACATCAATAAAAGAATTGCCAACATCAGTTTGGCGCAATAACAAGCTTTATACTTTGGTTCTTCATTCCTGTAAAAAACTGGTGAATTTTCCTGAAAGACCAAAACTTGAGGATTTACCTCTCGTATCCTCCTCTGAAAGGCCAAATATGGATGAACTATGGACTTTGTCATCCTTAGCAGATTTATCACTAAAAGGAAGCACTATTGAAAATTTACCTGCAAGCATCAAAGATCTTCCTAGTCTAAAAAAACTTACCTTGACTGAGTGCACGAAGCTGCGGTCCTTACCAAGCCTTCCACCATCCTTAGAAGACTTATCCTTAGATGAAAGTAATATTGTGTGCTTACCTGTAAGTATCAAAGATCTTTCTCATTTGAGAAAACTTGCCCTAATGAACCACAAGAAGTTTTTGTCTCCACAGGATCATCCACCATCTTTGAATGAAATTAAAGTCGATCCACATCTTGTGAGCATGAAAGGTCTTTCTCAACTACAGAAGTTTCCTCAGGTTAAGTGGAAAAGCTTTCATTCTCTACCAGAGCTTCCACCATTCTTGGAAGAATTTTCACTAAGTGAAAGCAATATTAAGTGCATACCTGAAAGCATTAAATATCTTTCACATCTGAGGAAACTAGCCTTAACAAAGTGCACGAGGCTTCAGTGTTTACCAGAGCTTCCGCCAACTTTGGAAGATTTGTTTGTAAGTGGATGTGACATTGAAAGCTTGCCCATAAGCATCAAATATCTAGTTCGTCTGCGAAAGATCACCTTAATTGAGTGCAAGAAGCTCAAGGCTCTACCAGAGCTCCCACAATGCCTGCAATCATTGTGTGTAGCTGACTGCAGATCACTCACGATTGTTCAAAGTACAAAGAATATCTTAATAGAAGATAGATATGCATTCTATTATAATTGCATAAACTTAGACCAAAAGTCGCGCAACAATATCATTGCAGATTCGCCCTTTGAGGCAGCATATACTTCTTTGAAAGAAAGAACACCTCTTGGTCCTCTTATTTCTATTTGTTTGCCAGGAACTGAAATCCCAGACTGGTTCAGCTACCAATCAACAAGTTCTTCACTGGACATGGAAATTCCTCTAGAGTGGTTTGTTGACTCGATGTTCTTAGGTTTTGCTCTGTGCCTTGTAATTGGTGGTTTCCAACAGAACAGTTATGAAGGGTATGATCCAGATATCAATTGTTATCACTTTGTAAAATCTGCCTCCTACTCTGGCCCCAGTGTTCCCTTTCTTGGCCATTGCACAACTGTAATGCAGGTGCCAAGAGGTTTTAATTCAGATCATATATTTATATGCTACTATCCCACTTTTAATGCCTCTATACCGCAAGACATCAAGGATTTAAGCTTGTACTATGATGCCAATAACCCAAGACTGAGAGTAATCTTTAAATTTAAGGGTCCATCTCAACGGTTGGACATTGTTAAGAAGTGCGGGGTCAGACCTCTTTTGATTGCAAATACTGAGAAGCTTCACGTAGAAAGTGAACAGCAACCTGAATAG 4008 0.3937 MLDGGIKSSTRLRQSSSCSCPPRMVKISPEPSSSSFSSTAPLKRHDVFISFRGEDTRSGFTSHLYAAFQHNKIQAFIDNRLHKGEEISPSIFEAIKHSNLSLVVLSKYYASSTWCLRELAKILELKKRGGHTVIPVFYKIDPSHVRKQTGTYGMAFQKYQRDVKQNMAMLQKWKAALTEVADIVGWELKNFRTEYELIGEIVKDVMQKLNHMYPTEVKETLVGIDQNLAPIESLLRIRSKEVRIIGIWGMGGLGKTTIAGALFAKLSSQFEASCFLANVKEEHEKQGLDYLRNKLLSEILEDVNPHISTSKVRTTFVMKRLRQKKVLIVLDDVDDPKKLEYLAAQHDCLGSGSRVIVTTRDKHVLSRGVDAIYEVKGLSLHHAVRLFSLNSFGKTYPERGFEMLSKQAVDHANGNPLALKVLGSVLHSRNEQQWDNALRKFKKVPNAEIQNVLRWSYDRLDYEQKNMFLDIACFFRGENKENVIRLLDICGFYAYIGIKVLLEKGLITFSDEGNVCMHELIQEMGWEIVHQESINDPGRRSRLWDLKEVYDVLKNNRGTEAVEGIILDVSQVRVLLLNYETFSRMVNMRFLKFYMGRGRKCNLHLPSGLESLPNKLMYLQWDGYPSKSLPSTFCPDNLVVLSMMESHVEKLWDGIKSLPSLKELNLRASKNLTKLPDLSQAPNLETIDVSYCTSLLHIPLSIQHVKRLLLFNLESCKSLKSHPRNIHLSSLEMFILRRCSSLDEFPLTSENMTRLDLRETAIADFPESVWQHLNKLVYLNLESCNKLKNLTSKIHLKSLQILNMRDCSILEEFSVTSENMEYLNLRGTSIKELPTSVWRNNKLYTLVLHSCKKLVNFPERPKLEDLPLVSSSERPNMDELWTLSSLADLSLKGSTIENLPASIKDLPSLKKLTLTECTKLRSLPSLPPSLEDLSLDESNIVCLPVSIKDLSHLRKLALMNHKKFLSPQDHPPSLNEIKVDPHLVSMKGLSQLQKFPQVKWKSFHSLPELPPFLEEFSLSESNIKCIPESIKYLSHLRKLALTKCTRLQCLPELPPTLEDLFVSGCDIESLPISIKYLVRLRKITLIECKKLKALPELPQCLQSLCVADCRSLTIVQSTKNILIEDRYAFYYNCINLDQKSRNNIIADSPFEAAYTSLKERTPLGPLISICLPGTEIPDWFSYQSTSSSLDMEIPLEWFVDSMFLGFALCLVIGGFQQNSYEGYDPDINCYHFVKSASYSGPSVPFLGHCTTVMQVPRGFNSDHIFICYYPTFNASIPQDIKDLSLYYDANNPRLRVIFKFKGPSQRLDIVKKCGVRPLLIANTEKLHVESEQQPE* 1336
       

Annotation information

Select Seq ID Length Analysis Description Start End IPR GO
Pvu2g1011 1335 MobiDBLite consensus disorder prediction 8 39 - -
Pvu2g1011 1335 Gene3D - 378 461 IPR042197 -
Pvu2g1011 1335 SMART till_3 44 183 IPR000157 GO:0007165
Pvu2g1011 1335 Gene3D - 210 372 IPR027417 -
Pvu2g1011 1335 SUPERFAMILY P-loop containing nucleoside triphosphate hydrolases 204 471 IPR027417 -
Pvu2g1011 1335 SUPERFAMILY Toll/Interleukin receptor TIR domain 40 186 IPR035897 -
Pvu2g1011 1335 SUPERFAMILY L domain-like 819 1140 - -
Pvu2g1011 1335 Gene3D Ribonuclease Inhibitor 984 1121 IPR032675 -
Pvu2g1011 1335 PRINTS Disease resistance protein signature 244 259 - -
Pvu2g1011 1335 PRINTS Disease resistance protein signature 320 334 - -
Pvu2g1011 1335 PRINTS Disease resistance protein signature 412 426 - -
Pvu2g1011 1335 PRINTS Disease resistance protein signature 904 920 - -
Pvu2g1011 1335 Gene3D Ribonuclease Inhibitor 752 817 IPR032675 -
Pvu2g1011 1335 Gene3D Ribonuclease Inhibitor 818 983 IPR032675 -
Pvu2g1011 1335 Gene3D Ribonuclease Inhibitor 547 751 IPR032675 -
Pvu2g1011 1335 SUPERFAMILY L domain-like 517 864 - -
Pvu2g1011 1335 Gene3D - 42 209 IPR035897 -
Pvu2g1011 1335 PANTHER RESISTANCE PROTEIN (TIR-NBS-LRR CLASS), PUTATIVE-RELATED 772 932 - -
Pvu2g1011 1335 PANTHER RESISTANCE PROTEIN (TIR-NBS-LRR CLASS), PUTATIVE-RELATED 882 1060 - -
Pvu2g1011 1335 PANTHER RESISTANCE PROTEIN (TIR-NBS-LRR CLASS), PUTATIVE-RELATED 38 788 - -
Pvu2g1011 1335 Pfam C-JID domain 1171 1316 IPR045344 -
Pvu2g1011 1335 ProSiteProfiles TIR domain profile. 43 209 IPR000157 GO:0007165
Pvu2g1011 1335 Pfam NB-ARC domain 232 451 IPR002182 GO:0043531
Pvu2g1011 1335 Pfam Leucine Rich Repeat 637 656 IPR011713 -
Pvu2g1011 1335 PANTHER LEUCINE-RICH REPEAT-CONTAINING PROTEIN 772 932 IPR044974 GO:0006952
Pvu2g1011 1335 PANTHER LEUCINE-RICH REPEAT-CONTAINING PROTEIN 38 788 IPR044974 GO:0006952
Pvu2g1011 1335 PANTHER LEUCINE-RICH REPEAT-CONTAINING PROTEIN 882 1060 IPR044974 GO:0006952
Pvu2g1011 1335 Pfam TIR domain 45 224 IPR000157 GO:0007165
Pvu2g1011 1335 MobiDBLite consensus disorder prediction 1 39 - -
       

Duplication type information

Select Gene Chromosome Start End Duplicated_type
Pvu2g1011 Pvu-Chr2 18980233 18985595 Dispersed/Transposed
       

Functional genes information

Select Gene Gene_start Gene_end Function Ath_gene Identity(%) E-value Score
Pvu2g1011 23 837 WRKY Transcription Factor Family AT4G12020 36.823 7.57e-131 442
       

Pathway information

Select Query KO Definition Second KO KEGG Genes ID GHOSTX Score
Pvu2g1011 - - gmx:100797269 2200.63